評論
打印
A new Cochrane Review, published in the Cochrane Library today and presented at the ERS International Congress, has found evidence from randomised trials, that taking an oral vitamin D supplement in addition to standard asthma medication is likely to reduce severe asthma attacks. Asthma is a common chronic2 disease affecting about 300 million people worldwide. The symptoms of asthma include wheezing3, coughing, chest tightness and shortness of breath.
今天發表在Cochrane圖書館并在ERS國際大會上發表的一篇新的《Cochrane評論》發現，隨機試驗的證據表明，除了標準哮喘藥物外，口服維生素D補充劑可能會減少嚴重哮喘發作。哮喘是一種常見的慢性疾病，影響著全世界約3億人。哮喘的癥狀包括喘息、咳嗽、胸悶和呼吸急促。
Low blood levels of vitamin D have been linked to increased risk of asthma attacks in children and adults with asthma. There has been a growing interest in the potential role of vitamin D in asthma management because it might help to reduce upper respiratory infections, (such as the common cold) that can lead to exacerbations of asthma.
血液中維生素D水平低與哮喘兒童和成人哮喘發作風險增加有關。人們對維生素D在哮喘管理中的潛在作用越來越感興趣，因為它可能有助于減少可能導致哮喘惡化的上呼吸道感染（如普通感冒）。
The researchers found that giving an oral vitamin D supplement reduced the risk of severe asthma attacks requiring hospital admission or emergency department attendance from 6% to around 3%.They also found that vitamin D supplementation reduced the rate of asthma attacks needing treatment with steroid tablets. These results are based largely on trials in adults. They also found that vitamin D did not improve lung function or day-to-day asthma symptoms, and that it did not increase the risk of side effects at the doses that were tested.
研究人員發現，口服維生素D補充劑可將需要住院或急診的嚴重哮喘發作風險從6%降低到3%左右。他們還發現，補充維生素D可降低需要類固醇片治療的哮喘發作率。這些結果主要基于對成年人的試驗。他們還發現，維生素D不會改善肺功能或日常哮喘癥狀，在測試劑量下也不會增加副作用的風險。
本文轉載自英語閱讀網，如有侵權，請聯系我們刪除。
